Allergic Rhinitis - Pipeline Review, H2 2018

Allergic Rhinitis - Pipeline Review, H2 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H2 2018, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape.

Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy runny nose, sneezing, swollen eyelids, itchy mouth, throat, ears.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Allergic Rhinitis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Allergic Rhinitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 7, 13, 3, 1, 11, 2 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 2 and 4 molecules, respectively.

Allergic Rhinitis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Allergic Rhinitis (Respiratory).
- The pipeline guide reviews pipeline therapeutics for Allergic Rhinitis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Allergic Rhinitis (Respiratory) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Allergic Rhinitis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Allergic Rhinitis (Respiratory)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Allergic Rhinitis (Respiratory).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Allergic Rhinitis (Respiratory) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 5
Allergic Rhinitis - Overview 6
Allergic Rhinitis - Therapeutics Development 7
Allergic Rhinitis - Therapeutics Assessment 15
Allergic Rhinitis - Companies Involved in Therapeutics Development 23
Allergic Rhinitis - Drug Profiles 36
Allergic Rhinitis - Dormant Projects 116
Allergic Rhinitis - Discontinued Products 123
Allergic Rhinitis - Product Development Milestones 125
Appendix 135

List Of Tables


Number of Products under Development for Allergic Rhinitis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Companies, H2 2018 (Contd..2), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Allergic Rhinitis - Pipeline by Accolade Pharmaceuticals LLC, H2 2018
Allergic Rhinitis - Pipeline by AFFiRiS AG, H2 2018
Allergic Rhinitis - Pipeline by ALK-Abello AS, H2 2018
Allergic Rhinitis - Pipeline by AlleCures Inc, H2 2018
Allergic Rhinitis - Pipeline by AOBiome LLC, H2 2018
Allergic Rhinitis - Pipeline by ASIT Biotech SA, H2 2018
Allergic Rhinitis - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2018
Allergic Rhinitis - Pipeline by Chrysalis BioTherapeutics Inc, H2 2018
Allergic Rhinitis - Pipeline by CSPC Pharmaceutical Group Limited, H2 2018
Allergic Rhinitis - Pipeline by Daewon Pharm Co Ltd, H2 2018
Allergic Rhinitis - Pipeline by Fountain Biopharma Inc, H2 2018
Allergic Rhinitis - Pipeline by GlaxoSmithKline Plc, H2 2018
Allergic Rhinitis - Pipeline by Glenmark Pharmaceuticals Ltd, H2 2018
Allergic Rhinitis - Pipeline by HAL Allergy BV, H2 2018
Allergic Rhinitis - Pipeline by Hanlim Pharm Co Ltd, H2 2018
Allergic Rhinitis - Pipeline by iCo Therapeutics Inc, H2 2018
Allergic Rhinitis - Pipeline by Inimmune Corp, H2 2018
Allergic Rhinitis - Pipeline by Intrommune Therapeutics, H2 2018
Allergic Rhinitis - Pipeline by Laboratorios LETI SL, H2 2018
Allergic Rhinitis - Pipeline by Marinomed Biotech AG, H2 2018
Allergic Rhinitis - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2018
Allergic Rhinitis - Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2018
Allergic Rhinitis - Pipeline by Pfizer Inc, H2 2018
Allergic Rhinitis - Pipeline by Regeneron Pharmaceuticals Inc, H2 2018
Allergic Rhinitis - Pipeline by Stallergenes Greer plc, H2 2018
Allergic Rhinitis - Pipeline by The Geneva Biotech Center SA, H2 2018
Allergic Rhinitis - Pipeline by Xencor Inc, H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..1), H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..2), H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..3), H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..4), H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..5), H2 2018
Allergic Rhinitis - Dormant Projects, H2 2018 (Contd..6), H2 2018
Allergic Rhinitis - Discontinued Products, H2 2018
Allergic Rhinitis - Discontinued Products, H2 2018 (Contd..1), H2 2018

List Of Figures


Number of Products under Development for Allergic Rhinitis, H2 2018 12
Number of Products under Development by Companies, H2 2018 13
Number of Products under Development by Universities/Institutes, H2 2018 15
Number of Products by Top 10 Targets, H2 2018 20
Number of Products by Stage and Top 10 Targets, H2 2018 20
Number of Products by Top 10 Mechanism of Actions, H2 2018 22
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018 22
Number of Products by Routes of Administration, H2 2018 24
Number of Products by Stage and Routes of Administration, H2 2018 24
Number of Products by Molecule Types, H2 2018 26
Number of Products by Stage and Molecule Types, H2 2018 26

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2018

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2018The clinical trial report, Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2018 provides an overview of Allergic Rhino-Conjunctivitis clinical trials scenario. This report

USD 2500 View Report

Allergic Rhinitis Global Clinical Trials Review, H2, 2018

Allergic Rhinitis Global Clinical Trials Review, H2, 2018The clinical trial report, Allergic Rhinitis Global Clinical Trials Review, H2, 2018 provides an overview of Allergic Rhinitis clinical trials scenario. This report

USD 2500 View Report

Allergic Rhinitis Global Clinical Trials Review, H2, 2018

Allergic Rhinitis Global Clinical Trials Review, H2, 2018The clinical trial report, Allergic Rhinitis Global Clinical Trials Review, H2, 2018 provides an overview of Allergic Rhinitis clinical trials scenario. This report

USD 2500 View Report

Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2018

Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2018The clinical trial report, Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2018 provides an overview of Seasonal Allergic Rhinitis clinical trials

USD 2500 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available